Exagen Inc reports results for the quarter ended in December - Earnings Summary

Exagen

22/03/2022 21:01

* Exagen Inc  XGN.OQ  reported a quarterly adjusted loss
of 42
cents​​ per share for the quarter ended in December. The mean
expectation of six analysts for the quarter was for a loss of 50
cents per share.
    * Revenue rose 0.2% to $12.69 million from a year ago; 
analysts
expected $11.80 million. 
    * Exagen Inc's reported EPS for the quarter was a loss of 42
cents​.
    * The mean earnings estimate of analysts had risen by
about 2.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Exagen Inc shares had fallen by 29.6% this quarter.
    * The company reported a quarterly loss of $7.05 million.
    * Wall Street's median 12-month price target for Exagen Inc
is
$23.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 22 at 09:01 p.m.  ​All
figures in US dollars unless otherwise stated